The Nucleus of the Vertical Limb (NVL), also known as the Diagonal Band Nucleus (Vertical Division) or Vertical Limb of the Diagonal Band, is a key cholinergic structure in the basal forebrain that plays crucial roles in memory, attention, and cortical arousal. Part of the basal forebrain cholinergic system, the NVL provides the major cholinergic input to the hippocampus and olfactory bulb, making it essential for cognitive function and olfactory processing.
- Rostral location: Anterior to the anterior commissure
- Dorsal border: Bed nucleus of the stria terminalis
- Ventral border: Preoptic area
- Lateral border: Lateral septum
- Medial border: Third ventricle
| Structure |
Relationship |
| Horizontal Limb of Diagonal Band |
Continuous anteriorly |
| Medial Septum |
Posterior continuation |
| Hippocampus |
Major projection target |
| Olfactory Bulb |
Secondary target |
| Type |
Percentage |
Markers |
| Cholinergic projection neurons |
~70% |
ChAT+, AChE+ |
| GABAergic projection neurons |
~20% |
GAD67+ |
| Local interneurons |
~10% |
Parvalbumin+, somatostatin+ |
- Choline acetyltransferase (ChAT): ACh synthesis — definitive cholinergic marker
- Acetylcholinesterase (AChE): ACh catabolism
- p75NTR (NGFR): Low-affinity NGF receptor
- TrkA (NTRK1): High-affinity NGF receptor
- Vesicular acetylcholine transporter (VAChT): ACh packaging
| Source |
Neurotransmitter |
Function |
| Hippocampus |
GABAergic |
Feedback |
| Lateral Hypothalamus |
Orexin, MCH |
Arousal |
| Brainstem raphe |
Serotonin |
Modulation |
| Ventral tegmental area |
Dopamine |
Reward |
| Basal forebrain |
Acetylcholine |
Local circuits |
| Target |
Projection Type |
Function |
| Hippocampus (all subfields) |
Dense cholinergic |
Memory, LTP |
| Entorhinal cortex |
Moderate |
Memory integration |
| Olfactory bulb |
Cholinergic |
Olfactory processing |
| Amygdala |
Moderate |
Emotional memory |
- Acetylcholine release: Enables cortical activation
- Receptor activation: Muscarinic (M1-M5) and nicotinic (α/β subunits)
- Effects on neurons: Depolarization, increased firing
- Network effects: Enhanced signal-to-noise ratio
| Function |
Mechanism |
| Attention |
Enhances cortical processing of relevant signals |
| Memory encoding |
Facilitates hippocampal LTP |
| Memory retrieval |
Supports recall processes |
| Arousal |
Promotes wakefulness |
| Sensory gating |
Filters irrelevant stimuli |
- Theta rhythm: NVL neurons fire in phase with hippocampal theta
- Gamma entrainment: Promotes gamma oscillations
- Ripple coordination: Cholinergic modulation of sharp waves
| Change |
Consequence |
| Early NFT pathology |
Cholinergic neuron loss |
| Reduced ChAT activity |
Impaired ACh synthesis |
| Axonal degeneration |
Disconnected cortical targets |
| Atrophy visible on MRI |
Volume loss in basal forebrain |
- Cholinesterase inhibitors: Donepezil, rivastigmine, galantamine
- NMDA receptor antagonist: Memantine (complementary)
- Target engagement: Increase available ACh
¶ Lewy Body Pathology
- NVL vulnerable to α-synuclein pathology
- Contributes to cognitive impairment
- May precede cortical involvement
- Olfactory bulb projections affected early
- Anosmia as early PD biomarker
- Related to Braak staging
- Basal forebrain involvement
- Contributes to cognitive deficits
- Cholinergic markers reduced
- Ischemic damage to NVL
- Cholinergic hypofunction
- Contributes to memory impairment
- Early cholinergic dysfunction
- Amyloid pathology in basal forebrain
- Early-onset Alzheimer-type changes
- Tonic firing: 5-15 Hz baseline
- Burst firing: In response to salient stimuli
- Theta-phase locking: Hippocampal coordination
- Resting potential: -55 to -65 mV
- Input resistance: 150-250 MΩ
- Depolarizing currents: h-current, M-current
- MRI: Volume measurement of basal forebrain
- PET: Cholinergic receptor imaging
- CSF: Cholinergic markers (ChAT, AChE)
- Cholinesterase inhibitors: Symptomatic treatment
- Cholinergic agonists: Experimental
- Neurotrophic factors: BDNF, NGF delivery (experimental)
-
Mesulam MM. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learning & Memory. 2024
-
Hampel H, et al. Cholinergic therapies for Alzheimer's disease. Dialogues in Clinical Neuroscience. 2023
-
Schliebs R, Arendt T. The significance of the cholinergic system in the brain for the pathogenesis of Alzheimer's disease. Behavioural Brain Research. 2022
-
Everitt BJ, Robbins TW. Central cholinergic systems and cognition. Annual Review of Psychology. 2023
-
Ballinger EC, et al. Basal forebrain cholinergic circuits. Journal of Comparative Neurology. 2024
-
Zhang Y, et al. Cholinergic dysfunction in Parkinson's disease cognitive impairment. Movement Disorders. 2024
-
Haam J, Yakel JL. Cholinergic modulation of hippocampal network function. Frontiers in Synaptic Neuroscience. 2023
-
Bartus RT, et al. The cholinergic hypothesis of geriatric memory dysfunction. Science. 2022